Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting

Journal of the American Board of Family Medicine: JABFM

article

David T. O’Gurek¹ 

[1]From the Department of Family & Community Medicine, Lewis Katz School of Medicine at Temple University

关键词: Controlled Substances;    COVID-19;    Disasters;    Opioids;    Pandemics;    Primary Health Care;    Retrospective Studies;    Substance Abuse;    Telemedicine;    Vulnerable Populations;   

DOI  :  10.3122/jabfm.2021.S1.200207

学科分类：过敏症与临床免疫学

来源: The American Board of Family Medicine

【 摘 要 】

Background: Despite changing federal regulations for providing telehealth services and provision of controlled substances during the COVID-19 pandemic, there is little guidance available for office-based opioid treatment (OBOT) programs integrated into primary care settings.

【 授权许可】

CC BY